Scientific Literature Search

Source record

Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Finlay C, Duty S.

J Neural Transm (Vienna) · 2014-02-21

DOI: 10.1007/s00702-014-1176-4PMID: 24557498

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson disease: Intestinal levodopa infusion in PD--the first randomized trial.

Katzenschlager R, Poewe W.

Nat Rev Neurol · 2014-02-18

DOI: 10.1038/nrneurol.2014.26PMID: 24535462

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The T-type calcium channel as a new therapeutic target for Parkinson's disease.

Yang YC, Tai CH, Pan MK, Kuo CC.

Pflugers Arch · 2014-02-18

DOI: 10.1007/s00424-014-1466-6PMID: 24531801

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.

Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P.

J Clin Invest · 2014-02-17

DOI: 10.1172/jci71640PMID: 24531549

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.

Tóth G, Gardai SJ, Zago W, Bertoncini CW, Cremades N, Roy SL, Tambe MA, Rochet JC, Galvagnion C, Skibinski G, Finkbeiner S, Bova M, Regnstrom K, Chiou SS, Johnston J, Callaway K, Anderson JP, Jobling MF, Buell AK, Yednock TA, Knowles TP, Vendruscolo M, Christodoulou J, Dobson CM, Schenk D, McConlogue L.

PLoS One · 2014-02-14

DOI: 10.1371/journal.pone.0087133PMID: 24551051

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Selective manipulation of aging: a novel strategy for the treatment of neurodegenerative disorders.

Moll L, El-Ami T, Cohen E.

Swiss Med Wkly · 2014-02-13

DOI: 10.4414/smw.2014.13917PMID: 24526357

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease.

Dumer AI, Oster H, McCabe D, Rabin LA, Spielman JL, Ramig LO, Borod JC.

J Int Neuropsychol Soc · 2014-02-13

DOI: 10.1017/s1355617714000046PMID: 24524211

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.

Rivera-Oliver M, Díaz-Ríos M.

Life Sci · 2014-02-13

DOI: 10.1016/j.lfs.2014.01.083PMID: 24530739

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.

Zhang D, Bordia T, McGregor M, McIntosh JM, Decker MW, Quik M.

Mov Disord · 2014-02-11

DOI: 10.1002/mds.25817PMID: 24515328

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.

Yan T, Rizak JD, Yang S, Li H, Huang B, Ma Y, Hu X.

PLoS One · 2014-02-10

DOI: 10.1371/journal.pone.0088404PMID: 24520383

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Primary cultured astrocytes from old rats are capable to activate the Nrf2 response against MPP+ toxicity after tBHQ pretreatment.

Alarcón-Aguilar A, Luna-López A, Ventura-Gallegos JL, Lazzarini R, Galván-Arzate S, González-Puertos VY, Morán J, Santamaría A, Königsberg M.

Neurobiol Aging · 2014-02-07

DOI: 10.1016/j.neurobiolaging.2014.01.143PMID: 24650792

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Targeting chelatable iron as a therapeutic modality in Parkinson's disease.

Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Garçon G, Rouaix N, Duhamel A, Jissendi P, Dujardin K, Auger F, Ravasi L, Hopes L, Grolez G, Firdaus W, Sablonnière B, Strubi-Vuillaume I, Zahr N, Destée A, Corvol JC, Pöltl D, Leist M, Rose C, Defebvre L, Marchetti P, Cabantchik ZI, Bordet R.

Antioxid Redox Signal · 2014-02-06

DOI: 10.1089/ars.2013.5593PMID: 24251381

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.728 articles found

Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Parkinson disease: Intestinal levodopa infusion in PD--the first randomized trial.

The T-type calcium channel as a new therapeutic target for Parkinson's disease.

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.

Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.

Selective manipulation of aging: a novel strategy for the treatment of neurodegenerative disorders.

Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease.

Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.

ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.

Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.

Primary cultured astrocytes from old rats are capable to activate the Nrf2 response against MPP+ toxicity after tBHQ pretreatment.

Targeting chelatable iron as a therapeutic modality in Parkinson's disease.

Filters